MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has unveiled promising data from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in treating plantar fibromatosis, presented at ...
MALVERN, Pa., Sept. 13, 2024 /PRNewswire/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that data from a clinical study of collagenase clostridium histolyticum (CCH) in patients with ...
That can't be a bad thing.” Xiaflex, based on a combination of several subtypes of collagenase enzyme derived from the bacterium Clostridium histolyticum, has completed a phase 3 trial in ...
Objective: The purpose of the present study was to demonstrate clinical equivalence between the application of collagenase ointment at 24- and 48-hour intervals in the healing of pressure ulcers.
J Midwifery Womens Health. 2008;53(2):115-122. The mechanisms of action for sterile water injections are not fully clear, but the Gate Control Theory is one logical explanation. This theory was ...